Cargando…
Reactivation of latent tuberculosis in a COVID-19 patient on corticosteroid treatment
Though the COVID-19 pandemic has made international headlines since 2020, behind the scenes, tuberculosis (TB) has remained a leading cause of global mortality. According to the WHO, TB is 1 of the top 10 causes of death globally, with about one-quarter of the world’s population infected. This case...
Autores principales: | Friedman, Aviva, DeGeorge, Katharine Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096484/ https://www.ncbi.nlm.nih.gov/pubmed/35545310 http://dx.doi.org/10.1136/bcr-2021-247562 |
Ejemplares similares
-
Development of pyogenic granuloma with strong vascular endothelial growth factor receptor-2 expression during ramucirumab treatment
por: Ibe, Tatsuya, et al.
Publicado: (2019) -
Angioedema, ACE inhibitor and COVID-19
por: Grewal, Ekjot, et al.
Publicado: (2020) -
Acute transverse myelitis in COVID-19 infection
por: Chow, Chian Chiang Nicholas, et al.
Publicado: (2020) -
Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
por: Morita, Chiyo, et al.
Publicado: (2018) -
Non-bacterial thrombotic endocarditis in a patient with COVID
por: Ahmad, Ali, et al.
Publicado: (2023)